Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -0.96 | $ -20.22M | 1 | 21.01M |
3/31/2025 | $ 1.26 | $ 26.42M | 1 | 20.94M |
12/31/2024 | $ 3.57 | $ 70.71M | 1 | 19.78M |
9/30/2024 | $ 6.9 | $ 144.12M | 1 | 20.88M |
6/30/2024 | $ 8.06 | $ 168.03M | 1 | 20.85M |
3/31/2024 | $ 11.06 | $ 182.29M | 1 | 16.48M |
12/31/2023 | $ 8.28 | $ 83.47M | 1 | 10.08M |
9/30/2023 | $ 10.17 | $ 102.71M | 1 | 10.1M |
6/30/2023 | $ 13.02 | $ 131.16M | 1 | 10.08M |
3/31/2023 | $ 15.73 | $ 157.76M | 1 | 10.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Equity [ $ 464.71M ] / (Shares WA [ 8.89M ] * Share Factor [ 1 ])
(=) BVPS [ $ 52.29 ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.99K |
---|---|
min | $ -30.1 |
max | $ 46.62 |
average | $ 10.29 |
median | $ 6.05 |
std | $ 12.43 |